抗纤维蛋白原相关蛋白1(FGL1)多克隆抗体
Anti-Fibrinogen Like Protein 1 (FGL1) Polyclonal Antibody
FGL-1; HFREP1; HP-041; LFIRE1; Hepassocin; Hepatocyte-derived fibrinogen-related protein 1; Liver fibrinogen-related protein 1
产品包装(模拟)
产品包装(模拟)
Human HepG2 cell line was fixed with 2% paraformaldehyde (10 min) , permeabilised with 0.1% BSA-Triton X-100,then stained with 20µg/ml rabbit Anti-human FGL1 Polyclonal Antibody (Catalog FAD022Hu01, red histogram) or Isotype control antibody (Catalog IS067-Rb01, green histogram), followed by 1µg/ml FITC-conjugated Anti-rabbit IgG Secondary Antibody (Catalog SAA544Rb18).
通过ISO 9001、ISO 13485质量体系认证
用法
Flow cytometry: 20µg/ml;
Optimal working dilutions must be determined by end user.
储存
经常使用则4°C保存。-20°C保存不超过一年。避免反复冻融。
赠品
增值服务
相关产品
| 编号 | 适用物种：Homo sapiens (Human，人) | 应用(仅供研究使用，不用于临床诊断！) |
| APD022Hu61 | 纤维蛋白原相关蛋白1(FGL1)活性蛋白 | Cell culture; Activity Assays. |
| EPD022Hu41 | 纤维蛋白原相关蛋白1(FGL1)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| EPD022Hu62 | 纤维蛋白原相关蛋白1(FGL1)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPD022Hu01 | 纤维蛋白原相关蛋白1(FGL1)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAD022Hu01 | 纤维蛋白原相关蛋白1(FGL1)多克隆抗体 | WB; IHC |
| FAD022Hu01 | 抗纤维蛋白原相关蛋白1(FGL1)多克隆抗体 | FCM |
| LAD022Hu71 | 纤维蛋白原相关蛋白1(FGL1)多克隆抗体(生物素标记) | WB; IHC; ICC. |
| LAD022Hu81 | 纤维蛋白原相关蛋白1(FGL1)多克隆抗体(异硫氰酸荧光素标记) | WB; IHC; ICC; IF. |
| MAD022Hu22 | 纤维蛋白原相关蛋白1(FGL1)单克隆抗体 | WB |
| MAD022Hu23 | 纤维蛋白原相关蛋白1(FGL1)单克隆抗体 | WB |
| MAD022Hu24 | 纤维蛋白原相关蛋白1(FGL1)单克隆抗体 | WB |
| MAD022Hu21 | 纤维蛋白原相关蛋白1(FGL1)单克隆抗体 | WB; IHC |
| SED022Hu | 纤维蛋白原相关蛋白1(FGL1)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMD022Hu | 纤维蛋白原相关蛋白1(FGL1)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
| KSD022Hu01 | 纤维蛋白原相关蛋白1(FGL1)检测试剂盒DIY材料(酶联免疫吸附试验法) | Main materials for "Do It (ELISA Kit) Yourself". |
参考文献
| 杂志 | 参考文献 |
| J Hepatol. | The role of Hepassocin in the development of non-alcoholic fatty liver disease[Pubmed: 23792031] |
| Diabetes Management | Serum hepassocin concentrations in diabetic patients with or without nonalcoholic fatty liver disease[Futuremedicine:Source] |
| United States Patent Application | Compositions and Methods for Diagnosing Lung Cancer[y2016:0077095.html] |
| Cell | Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC[Doi: 10.1016/j.cell.2018.09.053] |
| Liver Research | Do different bariatric surgery procedures impact hepassocin plasma levels in patients with type 2 diabetes mellitus?[] |
| Impacts of Different Modes of Bariatric Surgery on Plasma Levels of Hepassocin in Patients with Diabetes Mellitus[] |